About

Translating innovative science into a customer valued product is a significant challenge and requires the infusion of customer input during the early stages of clinical development.  Customers and partners are looking for positive results on meaningful endpoints to help balance new product risk.  Early stage commercialization strategic planning helps to improve asset value by aligning the development strategy with customer expectations.

About the Founder

After an extensive career at GlaxoSmithKline including customer facing roles, international health economics, project team membership and developing commercial strategies across the lifecycle, Mike started Burrows Life Sciences Associates, LLC.

Mike’s commercial experience includes working with development stage teams as early as first time in human through informing clinical development, drafting draft package inserts, brand management and standing before customers selling products. 

Combined with his inquisitive nature and a thorough understanding of the drug development process, Mike’s unique skill set helps his clients identify white space for pipeline products, find meaningful points of differentiation in crowded markets, inform clinical development strategy, evaluate in-license candidates and estimate potential value for markets or individual products with the customer’s perspective in mind.  In addition to his strategy development skills, Mike has developed exceptional consensus building, team leadership and facilitation skills.

He holds a Bachelor of Arts in Biology and Business Administration from Gettysburg College and an MBA/MHA from Pfeiffer University.  Originally from New Jersey, Mike now resides in the Research Triangle Park area of North Carolina.